Literature DB >> 30207918

Squamous-Cell Carcinoma of the Lung.

Luca Conti1, Simon Gatt1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30207918     DOI: 10.1056/NEJMicm1802514

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  MiR-210-3p targets CELF2 to facilitate progression of lung squamous carcinoma through PI3K/AKT pathway.

Authors:  Qiang Zhang; Yunzhen Wang
Journal:  Med Oncol       Date:  2022-08-16       Impact factor: 3.738

2.  The role of exosomal miR-181b in the crosstalk between NSCLC cells and tumor-associated macrophages.

Authors:  Junliang Ma; Shaolin Chen; Yingjie Liu; Hao Han; Ming Gong; Yongxiang Song
Journal:  Genes Genomics       Date:  2022-02-12       Impact factor: 2.164

3.  MiR-4652-5p Targets RND1 to Regulate Cell Adhesion and Promote Lung Squamous Cell Carcinoma Progression.

Authors:  Yafu Zhou; Jianhua Yan; Huiguo Chen; Wenwu Zhou; Guohua Xiao; Haoyu Zou; Jinsong Yang
Journal:  Appl Biochem Biotechnol       Date:  2022-03-25       Impact factor: 2.926

4.  Identification and Validation of Prognostic Markers for Lung Squamous Cell Carcinoma Associated with Chronic Obstructive Pulmonary Disease.

Authors:  Zheng Li; Dan Xu; Jing Jing; Jing Wang; Min Jiang; Fengsen Li
Journal:  J Oncol       Date:  2022-08-17       Impact factor: 4.501

5.  Determination of a prediction model for therapeutic response and prognosis based on chemokine signaling-related genes in stage I-III lung squamous cell carcinoma.

Authors:  Jinzhi Lai; Shiyu Yang; Shuqiang Chu; Tianwen Xu; Jingshan Huang
Journal:  Front Genet       Date:  2022-08-31       Impact factor: 4.772

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.